 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - NovoCure Ltd (NVCR)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-05 Sale | 2021-03-09 4:16 pm | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 2,918 | $131.53 | $383,805 | 33,259 (Direct) | View |
| 2021-03-05 Sale | 2021-03-09 4:17 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 4,550 | $131.53 | $598,461 | 107,423 (Direct) | View |
| 2021-03-23 Sale | 2021-03-25 4:40 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer | 3,892 | $140 | $544,880 | 36,306 (Direct) | View |
| 2021-03-31 Sale | 2021-04-02 4:14 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman | 7,928 | $134.12 | $1,063,303 | 650,393 (Direct) | View |
| 2020-02-28 Sale | 2021-04-08 4:18 pm | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM COO | 3,670 | $72.21 | $265,029 | 150,014 (Direct) | View |
| 2021-03-23 Sale(A) | 2021-04-09 4:25 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer | 2,835 | $140 | $396,900 | 33,471 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 5:59 pm | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 5,958 | $200 | $1,191,600 | 33,259 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 6:00 pm | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 6,000 | $198.84 | $1,193,035 | 72,045 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 6:01 pm | NovoCure Ltd | NVCR | Danziger Asaf CEO | 97,973 | $196.34 | $19,236,322 | 8,184 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 6:29 pm | NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman | 95,000 | $199.55 | $18,957,452 | 555,393 (Direct) | View |
| 2021-05-03 Sale | 2021-05-05 4:09 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,043 | $200.86 | $209,493 | 102,562 (Direct) | View |
| 2021-05-05 Sale | 2021-05-06 4:15 pm | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $199.67 | $199,670 | 72,045 (Direct) | View |
| 2021-05-05 Sale | 2021-05-06 4:17 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 1,290 | $199.67 | $257,574 | 101,272 (Direct) | View |
| 2021-05-10 Sale | 2021-05-12 4:13 pm | NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer | 5,650 | $189.65 | $1,071,522 | 31,667 (Direct) | View |
| 2021-05-10 Sale | 2021-05-12 4:15 pm | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 4,095 | $184.38 | $755,055 | 30,997 (Direct) | View |
| 2021-05-12 Sale | 2021-05-14 4:07 pm | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 1,943 | $180.48 | $350,673 | 29,054 (Direct) | View |
| 2021-05-27 Sale | 2021-05-28 4:36 pm | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 1,833 | $200 | $366,600 | 29,054 (Direct) | View |
| 2021-06-07 Sale | 2021-06-08 4:49 pm | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $204.55 | $204,550 | 72,045 (Direct) | View |
| 2021-06-10 Sale | 2021-06-11 4:26 pm | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 23,540 | $215 | $5,061,100 | 77,732 (Direct) | View |
| 2021-07-06 Sale | 2021-07-08 5:23 pm | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $183.54 | $183,540 | 72,859 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-04 Sale | 2021-03-08 4:26 pm | N/A N/A | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM COO | 3,854 | $137.55 | 156,688 (Direct) | View |
| 2021-03-05 Exercise | 2021-03-09 4:17 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 13,987 | $7.15 | 111,973 (Direct) | View |
| 2021-03-05 Exercise | 2021-03-09 4:17 pm | N/A 2027-02-21 | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 13,987 | $0 | 0 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 4:06 pm | N/A N/A | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM COO | 3,004 | $130.81 | 153,684 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 4:07 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 765 | $130.81 | 90,045 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 4:08 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 2,404 | $130.81 | 67,714 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley CFO | 765 | $130.81 | 35,893 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 4:10 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 2,627 | $130.81 | 104,796 (Direct) | View |
| 2021-03-08 Sale | 2021-03-10 4:10 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 3,524 | $131.09 | 101,272 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 4:40 pm | N/A N/A | NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer | 3,892 | $47.04 | 40,198 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 4:40 pm | N/A 2029-03-21 | NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer | 3,892 | $0 | 3,892 (Direct) | View |
| 2021-03-31 Exercise | 2021-04-02 4:14 pm | N/A N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman | 9,259 | $125.25 | 658,321 (Direct) | View |
| 2021-03-31 Exercise | 2021-04-02 4:14 pm | 2019-03-31 N/A | NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman | 9,259 | $0 | 0 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:59 pm | N/A N/A | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 1,833 | $47.56 | 35,092 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:59 pm | N/A N/A | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 651 | $83.3 | 33,910 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:59 pm | N/A N/A | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 3,474 | $69.37 | 36,733 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:59 pm | N/A 2029-05-07 | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 1,833 | $0 | 10,998 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:59 pm | N/A 2029-07-30 | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 651 | $0 | 3,904 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 5:59 pm | N/A 2030-03-02 | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 3,474 | $0 | 19,404 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 6:00 pm | N/A N/A | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 6,000 | $31.45 | 78,045 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-15 6:00 pm | N/A 2028-05-31 | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 6,000 | $0 | 6,345 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-05 4:09 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 2,333 | $204.1 | 103,605 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-05 4:09 pm | 2021-05-01 N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 2,333 | $0 | 0 (Direct) | View |
| 2021-05-05 Exercise | 2021-05-06 4:15 pm | N/A N/A | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $31.45 | 73,045 (Direct) | View |
| 2021-05-05 Exercise | 2021-05-06 4:15 pm | N/A 2028-05-30 | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $0 | 5,345 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-12 4:13 pm | N/A N/A | NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer | 3,846 | $47.56 | 37,317 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-12 4:13 pm | N/A 2029-05-07 | NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer | 3,846 | $0 | 3,845 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-12 4:15 pm | N/A N/A | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 1,833 | $47.56 | 35,092 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-12 4:15 pm | N/A 2029-05-07 | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 1,833 | $0 | 9,165 (Direct) | View |
| 2021-05-27 Exercise | 2021-05-28 4:36 pm | N/A N/A | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 1,833 | $47.56 | 30,887 (Direct) | View |
| 2021-05-27 Exercise | 2021-05-28 4:36 pm | N/A 2029-05-07 | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 1,833 | $0 | 7,332 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 4:49 pm | N/A N/A | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $31.45 | 73,045 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 4:49 pm | N/A 2028-05-30 | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $0 | 4,345 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:18 pm | N/A N/A | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 814 | $0 | 72,859 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:18 pm | N/A 2031-06-09 | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,499 | $0 | 1,499 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:19 pm | N/A N/A | NovoCure Ltd | NVCR | Hung David Director | 814 | $0 | 6,714 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:19 pm | N/A 2031-06-09 | NovoCure Ltd | NVCR | Hung David Director | 1,499 | $0 | 1,499 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:21 pm | N/A N/A | NovoCure Ltd | NVCR | HILLEMAN JERYL L Director | 814 | $0 | 4,214 (Direct) | View |
| 2021-06-09 Disposition | 2021-06-11 4:21 pm | N/A N/A | NovoCure Ltd | NVCR | HILLEMAN JERYL L Director | 1,270 | $210.01 | 2,944 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:21 pm | N/A 2031-06-09 | NovoCure Ltd | NVCR | HILLEMAN JERYL L Director | 1,499 | $0 | 1,499 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:22 pm | N/A N/A | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 814 | $0 | 161,944 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:22 pm | N/A 2031-06-09 | NovoCure Ltd | NVCR | VERNON W ANTHONY Director | 1,499 | $0 | 1,499 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:22 pm | N/A N/A | NovoCure Ltd | NVCR | Madden Martin J. Director | 814 | $0 | 15,620 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:22 pm | N/A 2031-06-09 | NovoCure Ltd | NVCR | Madden Martin J. Director | 1,499 | $0 | 1,499 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:24 pm | N/A N/A | NovoCure Ltd | NVCR | McCoy Sherilyn S Director | 814 | $0 | 6,714 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:24 pm | N/A 2031-06-09 | NovoCure Ltd | NVCR | McCoy Sherilyn S Director | 1,499 | $0 | 1,499 (Direct) | View |
| 2021-07-06 Exercise | 2021-07-08 5:23 pm | N/A N/A | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $31.45 | 73,859 (Direct) | View |
| 2021-07-06 Exercise | 2021-07-08 5:23 pm | N/A 2028-05-30 | NovoCure Ltd | NVCR | LEUNG GABRIEL Director | 1,000 | $0 | 3,345 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:26 pm | N/A N/A | NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel | 154 | $137.12 | 67,868 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:29 pm | N/A N/A | NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer | 154 | $137.12 | 77,886 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:31 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf CEO | 118 | $137.12 | 8,302 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:32 pm | N/A N/A | NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer | 90 | $137.12 | 29,144 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:34 pm | N/A N/A | NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM COO | 66 | $137.12 | 150,080 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:35 pm | N/A N/A | NovoCure Ltd | NVCR | Cordova Ashley CFO | 100 | $137.12 | 35,993 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:36 pm | N/A N/A | NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer | 154 | $137.12 | 90,199 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:38 pm | N/A N/A | NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer | 113 | $137.12 | 31,780 (Direct) | View |